Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucanthone in Glioblastoma Multiforme
NCT01587144Phase 2Terminated
- Sponsor
- Spectrum Pharmaceuticals, Inc.
- Start
- Jun 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of lucanthone in glioblastoma multiforme (GBM), sponsored by Spectrum Pharmaceuticals, Inc.. Started Jun 2012; status: terminated.
02
Drugs
lucanthone
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT01587144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01587144.